miR‐495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression

Zhenyou Zou(Purdue University West Lafayette), Yong Liang(Taizhou University)
Journal of Cellular and Molecular Medicine
April 14, 2017
Cited by 63


Related Papers